SafeTy and Outcome of contemPorary Treatment Strategies for Cardiogenic SHOCK
Recruiting
Observational Study
Cardiogenic Shock
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 2,500 (estimated)
- Sponsor
- Universitätsklinikum Hamburg-Eppendorf · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
International, observational registry to investigate the outcome in patients with cardiogenic shock. The primary aim of this study is to investigate the clinical outcome of patients in cardiogenic shock.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients with cardiogenic shock treated at a tertiary care hospital.
Exclusion Criteria:
* Age ≤17 years.
Contacts